Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus

J Infect Dis. 2000 Jul;182(1):28-35. doi: 10.1086/315661. Epub 2000 Jul 6.

Abstract

Many studies have shown that patients infected with hepatitis C virus (HCV) of genotype 2 have better response to interferon (IFN)-alpha treatment than genotype 1 patients; however, the mechanisms responsible for this difference are not understood. In this study, viral dynamics during high-dose IFN induction treatment were compared between the genotypes. Patients in each group received 10 MU of IFN-alpha2b for 14 days, and HCV RNA levels were frequently determined. Nonlinear fitting, both individually for each patient and using a mixed-effects approach, of the viral kinetic data to a mathematical model of the IFN effect on HCV infection was performed. The antiviral effectiveness of IFN in blocking virus production, the free virion clearance rate, and the HCV-infected cell death rate were all significantly higher for genotype 2 patients than for genotype 1 patients. Thus, the better response rate of patients infected with HCV genotype 2 is multifactorial. This is the first finding of a difference in viral dynamics between subtypes of the same virus and demonstrates the importance of subtype-specific virus-host-drug interactions.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antiviral Agents / therapeutic use
  • Apoptosis
  • Female
  • Genotype
  • Hepacivirus / genetics
  • Hepacivirus / physiology*
  • Hepatitis C / drug therapy
  • Hepatitis C / immunology
  • Hepatitis C / pathology
  • Hepatitis C / virology*
  • Humans
  • Interferon-alpha / therapeutic use
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Models, Theoretical
  • RNA, Viral / metabolism

Substances

  • Antiviral Agents
  • Interferon-alpha
  • RNA, Viral